Report Highlights
The Chinese market for medical polymers was valued at nearly $1.7 billion in 2011 and $1.9 billion in 2012. The market is expected to reach $4 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 16.1%.
Report Includes
- An overview of the Chinese market for medical polymer materials, which are resins, fibers, elastomers, and other polymers.
- Analyses of market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Coverage of three parts of the Chinese medical polymer industry: medical resins and fibers, medical elastomers, and biodegradable medical polymer materials.
- Discussion of applications for medical polymers, including the cardiovascular system, oncology, tissue engineering, medicine, medical packing, ophthalmology, medical adhesive and sutures, and medical equipment.
- Reviews of trends in price and price/performance.
- Comprehensive profiles of major companies operating in China and a breakdown of market shares.
SCOPE OF REPORT
The report forecasts the size of the Chinese market in current U.S. dollars for medical polymers in value terms and/or volume terms for each material from 2012 through 2017. The report forecasts the Chinese market size for medical polymers such as PE, PP, PS, PVC, and PU. The forecasts are classified on the basis of product type, application, and geographical region.
The report also describes the important players in the Chinese medical polymer industry. They include homegrown companies, foreign companies, and joint ventures.
Analyst Credentials
Jason Chen has been an analyst and consultant for the polymer, composite, fiber, textile and energy industries for 18 years. He works as a researcher, writer and/or editor for the American Composites Manufacturers Association (ACMA), China Textile Academy (CTA), China Chemical Fiber Association (CCFA), International Fiber Journal, Filtration News, Platts Emission Daily, Vision Systems Design, Pesticide and Toxic Chemical News and MobileTex. Currently he is the chief scientist of a company endeavoring to reduce China's air and water pollution. He has a degree in Civil Engineering, Chemicals and Advanced Materials from Shantou University.
Related Reports
High-Performance Films: The U.S. Market
The U.S. market for high-performance films was valued at $12.4 billion in 2011, and is projected to reach $14.9 billion in 2017, a five-year compound annual growth rate (CAGR) of 3.7% from 2012 to 2017.
Recent Reports
Liquid Crystal Polymers: Global Markets
The global market for liquid crystal polymers is expected to grow from $957.5 million in 2023 to $1.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.1% from 2023 through 2028.
Plastics for Healthcare Packaging
The global market value of plastics for healthcare packaging is expected to grow from $32.1 billion in 2023 and should reach $46.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2023 to 2028.
Medical Plastics: Global Markets
The global market for medical plastics is estimated to increase from $25.6 billion in 2023 to reach $41.2 billion by 2028, at a compound annual growth rate (CAGR) of 10.0% from 2023 through 2028.
EMI/RFI: Materials and Technologies
The global market for EMI/RFI materials and technologies is expected to increase from $7.4 billion in 2023 to $9.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2023-2028.
Fluoropolymer Materials: Technologies and Global Markets
The global market volume for fluoropolymer materials is estimated to increase from 346.97 kilotons in 2023 to reach 442.79 kilotons by 2028, at a compound annual growth rate (CAGR) of 5.0% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More